130 related articles for article (PubMed ID: 38701136)
21. Increased expression of pleiotrophin is a prognostic marker for patients with gastric cancer.
Hu H; Li C; Cai S; Zhu C; Tian Y; Zheng J; Hu J; Chen C; Liu W
Hepatogastroenterology; 2014; 61(133):1478-82. PubMed ID: 25436328
[TBL] [Abstract][Full Text] [Related]
22. Pleiotrophin expression in astrocytic and oligodendroglial tumors and it's correlation with histological diagnosis, microvascular density, cellular proliferation and overall survival.
Peria FM; Neder L; Marie SK; Rosemberg S; Oba-Shinjo SM; Colli BO; Gabbai AA; Malheiros SM; Zago MA; Panepucci RA; Moreira-Filho CA; Okamoto OK; Carlotti CG
J Neurooncol; 2007 Sep; 84(3):255-61. PubMed ID: 17443289
[TBL] [Abstract][Full Text] [Related]
23. Diagnostic Value of Serum Concentration and Integrity of Circulating Cell-Free DNA in Breast Cancer: A Comparative Study With CEA and CA15-3.
Tang Z; Li L; Shen L; Shen X; Ju S; Cong H
Lab Med; 2018 Oct; 49(4):323-328. PubMed ID: 29701836
[TBL] [Abstract][Full Text] [Related]
24. Correlation of AGR2 expression with the incidence of metastasis in luminal breast cancer.
Kereh DS; Pieter J; Hamdani W; Haryasena H; Sampepajung D; Prihantono P
Breast Dis; 2021; 40(S1):S103-S107. PubMed ID: 34092584
[TBL] [Abstract][Full Text] [Related]
25. Significance of the expression of the growth factor pleiotrophin in pancreatic cancer patients.
Klomp HJ; Zernial O; Flachmann S; Wellstein A; Juhl H
Clin Cancer Res; 2002 Mar; 8(3):823-7. PubMed ID: 11895915
[TBL] [Abstract][Full Text] [Related]
26. Plasma mammaglobin messenger RNA in breast cancer patients as an addition to serum tumor.
El-Attar NI; Gaefar HA
Egypt J Immunol; 2007; 14(2):111-21. PubMed ID: 20306663
[TBL] [Abstract][Full Text] [Related]
27. The link between menin and pleiotrophin in the tumor biology of pancreatic neuroendocrine neoplasms.
He L; Boulant S; Stanifer M; Guo C; Nießen A; Chen M; Felix K; Bergmann F; Strobel O; Schimmack S
Cancer Sci; 2022 May; 113(5):1575-1586. PubMed ID: 35179814
[TBL] [Abstract][Full Text] [Related]
28. Expression of receptor protein tyrosine phosphatase ζ is a risk factor for triple negative breast cancer relapse.
Fu F; Xiao XI; Zhang T; Zou Q; Chen Z; Pei L; Su J; Yi W
Biomed Rep; 2016 Feb; 4(2):167-172. PubMed ID: 26893832
[TBL] [Abstract][Full Text] [Related]
29. Relationship between serum concentrations of the growth factor pleiotrophin and pleiotrophin-positive tumors.
Souttou B; Juhl H; Hackenbruck J; Röckseisen M; Klomp HJ; Raulais D; Vigny M; Wellstein A
J Natl Cancer Inst; 1998 Oct; 90(19):1468-73. PubMed ID: 9776412
[TBL] [Abstract][Full Text] [Related]
30. Pleiotrophin expression in human pancreatic cancer and its correlation with clinicopathological features, perineural invasion, and prognosis.
Yao J; Ma Q; Wang L; Zhang M
Dig Dis Sci; 2009 Apr; 54(4):895-901. PubMed ID: 18716876
[TBL] [Abstract][Full Text] [Related]
31. Diagnostic and prognostic potential of serum angiopoietin-2 expression in human breast cancer.
Li P; He Q; Luo C; Qian L
Int J Clin Exp Pathol; 2015; 8(1):660-4. PubMed ID: 25755760
[TBL] [Abstract][Full Text] [Related]
32. Association of Midkine and Pleiotrophin Gene Polymorphisms With Systemic Lupus Erythematosus Susceptibility in Chinese Han Population.
Wang P; Mao YM; Zhao CN; Wang JB; Li XM; Ye DQ; Pan HF
Front Immunol; 2020; 11():110. PubMed ID: 32153561
[TBL] [Abstract][Full Text] [Related]
33. The prognostic relevance of urokinase-type plasminogen activator (uPA) in the blood of patients with metastatic breast cancer.
Banys-Paluchowski M; Witzel I; Aktas B; Fasching PA; Hartkopf A; Janni W; Kasimir-Bauer S; Pantel K; Schön G; Rack B; Riethdorf S; Solomayer EF; Fehm T; Müller V
Sci Rep; 2019 Feb; 9(1):2318. PubMed ID: 30783124
[TBL] [Abstract][Full Text] [Related]
34. Sublingual Nodules: Diagnostic Markers of Metastatic Breast Cancer.
Yang X; Zhu CH; Cao R; Hao J; Wu XZ
Chin J Integr Med; 2018 Oct; 24(10):741-745. PubMed ID: 29667148
[TBL] [Abstract][Full Text] [Related]
35. The blood level of thioredoxin 1 as a supporting biomarker in the detection of breast cancer.
Lee YJ; Kim Y; Choi BB; Kim JR; Ko HM; Suh KH; Lee JS
BMC Cancer; 2022 Jan; 22(1):12. PubMed ID: 34979986
[TBL] [Abstract][Full Text] [Related]
36. Serum levels of the angiogenic factor pleiotrophin in relation to disease stage in lung cancer patients.
Jäger R; List B; Knabbe C; Souttou B; Raulais D; Zeiler T; Wellstein A; Aigner A; Neubauer A; Zugmaier G
Br J Cancer; 2002 Mar; 86(6):858-63. PubMed ID: 11953815
[TBL] [Abstract][Full Text] [Related]
37. Melanoma angiogenesis and metastasis modulated by ribozyme targeting of the secreted growth factor pleiotrophin.
Czubayko F; Schulte AM; Berchem GJ; Wellstein A
Proc Natl Acad Sci U S A; 1996 Dec; 93(25):14753-8. PubMed ID: 8962127
[TBL] [Abstract][Full Text] [Related]
38. Co-expression of midkine and pleiotrophin predicts poor survival in human glioma.
Ma J; Lang B; Wang X; Wang L; Dong Y; Hu H
J Clin Neurosci; 2014 Nov; 21(11):1885-90. PubMed ID: 25001988
[TBL] [Abstract][Full Text] [Related]
39. Pleiotrophin is highly expressed by myeloma cells and promotes myeloma tumor growth.
Chen H; Gordon MS; Campbell RA; Li M; Wang CS; Lee HJ; Sanchez E; Manyak SJ; Gui D; Shalitin D; Said J; Chang Y; Deuel TF; Baritaki S; Bonavida B; Berenson JR
Blood; 2007 Jul; 110(1):287-95. PubMed ID: 17369488
[TBL] [Abstract][Full Text] [Related]
40. Serum HER2/ECD value in stage I and II early breast cancer: need of a lower cut-off?
Badzek S; Kelovic VL; Plestina S; Humar I; Veir Z; Mihaljevic Z
Wien Klin Wochenschr; 2011 Dec; 123(23-24):726-31. PubMed ID: 22113445
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
